SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002933
Filing Date
2021-11-04
Accepted
2021-11-04 07:26:06
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20210930.htm   iXBRL 10-Q 3140182
2 EX-31.1 dyn-ex31_1.htm EX-31.1 12998
3 EX-31.2 dyn-ex31_2.htm EX-31.2 13210
4 EX-32.1 dyn-ex32_1.htm EX-32.1 6975
5 EX-32.2 dyn-ex32_2.htm EX-32.2 6882
  Complete submission text file 0000950170-21-002933.txt   9212966

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20210930.xsd EX-101.SCH 48837
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyn-20210930_cal.xml EX-101.CAL 51660
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20210930_pre.xml EX-101.PRE 295555
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyn-20210930_def.xml EX-101.DEF 123782
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20210930_lab.xml EX-101.LAB 402525
11 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20210930_htm.xml XML 1697646
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 211378000
SIC: 2834 Pharmaceutical Preparations